Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
clinical trials in mexico
As a leading CRO in LATAM, we specialize in supporting clinical trials in Mexico and throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trials in Mexico

Clinical Trials in México – Cohortias the CRO of LATAM

Clinical studies are an essential part of the pharmaceutical industry.

These studies help to ensure the safety and efficacy of new drugs and medical devices. Mexico has become an increasingly popular destination for clinical trials due to its large patient population and well-established healthcare system.

In this blog post, we will explore the current state of clinical studies in Mexico.

Mexico has a long history of conducting clinical studies.

The country’s healthcare system is made up of both public and private institutions, which offer a range of healthcare services to its population.

The government is actively involved in healthcare, and the country has several regulatory bodies responsible for overseeing clinical trials.

These include the Federal Commission for Protection against Sanitary Risks (COFEPRIS) and the National Bioethics Commission (CONBIOETICA).

Mexico’s healthcare system has undergone significant reforms in recent years, resulting in better access to healthcare for its citizens.

This has made Mexico an attractive destination for clinical trials.

Mexico has a large patient population, which is diverse and represents a range of ethnicities and socioeconomic backgrounds.

This diversity is important in clinical trials, as it helps to ensure that the results of the study can be applied to a broader population.

Another advantage of conducting clinical trials in Mexico is the country’s relatively low cost of living.

This translates into lower costs for clinical trials, which can be attractive to pharmaceutical companies looking to save money.

Additionally, Mexico has a large pool of qualified healthcare professionals, including doctors, nurses, and clinical research coordinators, which can help ensure the success of clinical trials.

Despite these advantages, conducting clinical trials in Mexico is not without its challenges.

One of the main challenges is the need to navigate the country’s regulatory system. COFEPRIS is responsible for approving clinical trials in Mexico, and the process can be time-consuming and complex.

Additionally, there are strict ethical guidelines that must be followed when conducting clinical trials, which can be challenging for companies unfamiliar with Mexican regulations.

Another challenge is the need to ensure the safety of study participants. Mexico has a relatively high incidence of infectious diseases, which can pose a risk to study participants.

Additionally, there is a need to ensure that participants are properly informed about the risks and benefits of participating in a clinical trial.

This can be particularly challenging in populations with low health literacy.

Despite these challenges, there have been many successful clinical trials conducted in Mexico.

For example, a recent study conducted by the pharmaceutical company Novartis showed promising results for a new drug to treat heart failure.

The study, which involved more than 8,000 participants, was conducted in several countries, including Mexico.

The results of the study showed that the drug was effective in reducing the risk of hospitalization or death due to heart failure.

Another successful clinical trial conducted in Mexico was the phase III trial of the HPV vaccine.

This vaccine was developed to prevent the human papillomavirus (HPV), which can cause cervical cancer.

The trial, which involved more than 18,000 participants, showed that the vaccine was effective in preventing HPV infection and reducing the risk of cervical cancer.

In conclusion, clinical studies in Mexico are an important part of the pharmaceutical industry.

Mexico’s large and diverse patient population, well-established healthcare system, and relatively low cost of living make it an attractive destination for clinical trials.

However, navigating the country’s regulatory system and ensuring the safety of study participants can be challenging.

Despite these challenges, there have been many successful clinical trials conducted in Mexico, which have contributed to the development of new and effective drugs and medical devices.

Clinical Trials in Mexico

Clinical trials in Mexico

Cohortias the CRO of LATAM

If you are considering conducting clinical trials in Mexico, working with a reliable and experienced contract research organization (CRO) is essential to ensure that your trials are successful.

As a CRO in LATAM, Cohortias offers a wide range of services to help pharmaceutical and biotech companies navigate the clinical research landscape of the region.

Our team of experts has extensive knowledge and experience in conducting clinical trials in Mexico, as well as in other countries in Latin America. 

We can provide guidance and support throughout the entire clinical trial process, from protocol development to regulatory compliance and data management.

At Cohortias, we understand that each trial is unique, and we work closely with our clients to develop customized solutions that meet their specific needs and objectives. 

Our goal is to help our clients achieve their clinical trial goals efficiently and cost-effectively, while maintaining the highest level of quality and compliance.

So if you’re looking for a reliable and experienced partner for your clinical trials in Mexico, contact Cohortias today. 

Our team is ready to help you navigate the clinical research landscape of Latin America and ensure the success of your trials.

Clinical trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials in Mexico

The Cohortias Team

Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials in Mexico

Network & Partnerships